Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional triamcinolone vs hyaluronidase vs combination for hypertrophic scars and keloids
TCTR20241208002Phase 4Unknown
- Sponsor
- Srinakharinwirot University
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone, hyaluronidase in Hypertrophic Scar (HS), keloid, sponsored by Srinakharinwirot University. Status: unknown.
02
Drugs
triamcinolonehyaluronidase
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on TCTR20241208002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241208002.